Sanofi Consumer Healthcare India (NSE:SANOFICONR) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)


NSE:SANOFICONR Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
32 GF Score
Price ₹4,624.70
! 2 Warning Signs
View Full Analysis

What is Sanofi Consumer Healthcare India Cash Flow for Dividends?

Sanofi Consumer Healthcare India NSE:SANOFICONR +0.18% 32 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Sanofi Consumer Healthcare India's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Sanofi Consumer Healthcare India's annual payment of dividends increased from Dec. 2023 (₹0 Mil) to Dec. 2024 (₹-1,152 Mil) and increased from Dec. 2024 (₹-1,152 Mil) to Dec. 2025 (₹-1,267 Mil).

Sanofi Consumer Healthcare India Cash Flow for Dividends Related Terms

Sanofi Consumer Healthcare India Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Sanofi Consumer Healthcare India's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India Cash Flow for Dividends Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24 Dec25
Cash Flow for Dividends
0.00 -1,152.00 -1,267.00

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SANOFICONR
32GF Score
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Consumer Healthcare India Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Sanofi Consumer Healthcare India and its competitors.
Is Sanofi Consumer Healthcare India's Cash Flow for Dividends too high?
Sanofi Consumer Healthcare India's current Cash Flow for Dividends is ₹0 Mil. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Cash Flow for Dividends compare to LLY and JNJ?
Sanofi Consumer Healthcare India's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Sanofi Consumer Healthcare India and its competitors. Sanofi Consumer Healthcare India's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Cash Flow for Dividends of ₹0 Mil. The current Cash Flow for Dividends is ₹0 Mil. Sanofi Consumer Healthcare India's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sanofi Consumer Healthcare India Business Description

Other Exchanges 544250:India
Address Pirojshanagar, Eastern Express Highway, Unit 1104, 11th Floor, Godrej Two, Vikhroli East, Mumbai, MH, IND, 400079
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
32GF Score

Get the complete analysis for NSE:SANOFICONR

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,624.70
Price